Retrospective study of imatinib mesylate in patients with locally advanced tenosynovial giant cell tumor/pigmented villonodular synovitis (TGCT).
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2015
At a glance
- Drugs Imatinib (Primary)
- Indications Giant cell tumour of tendon sheath; Pigmented villonodular synovitis
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.